WORLD BANK GROUP has floated a tender for IFC Pharma Sector Diagnostic and Scoping. The project location is Ethiopia and the tender is closing on 29 Jun 2021. The tender notice number is 1275550, while the TOT Ref Number is 54324649. Bidders can have further information about the tender and can request the complete tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : Ethiopia

Summary : IFC Pharma Sector Diagnostic and Scoping

Deadline : 29 Jun 2021

Other Information

TOT Ref.No.: 54324649

Document Ref. No. : 1275550

Competition : ICB

Financier : World Bank (WB)

Purchaser's Detail

Purchaser : WORLD BANK GROUP
Africa Avenue (Bole Road) Addis Ababa Tel: +(251) 115176000
Ethiopia
Email :ethiopiaalert@worldbank.org

Tender Details

Expression of Interest are invited for IFC Pharma Sector Diagnostic and Scoping in Ethiopia. IFC intends to engage a Consultant to assist with the diagnostic and scoping of the pharmaceutical value chain in Ethiopia to identify the constraints and investment opportunities to unlock manufacturing capabilities. The relevant sub-sectors in the pharmaceutical value chain would include packaging, formulation, vaccines, biologics, fill & finish, API, laboratory reagents, veterinary medicine, medical devices, and logistics and distribution. Key objectives of the diagnosis and assessment are: - Identifying gaps in local manufacturing, product development, and operating capabilities and constraints, including assessment of the availability of raw materials and reliance on forex for importing ingredients. - Determining relevant products and services for investment and potential of import substitution/exports and exploring suitable regional markets for export opportunities. - Identifying the regulatory strengths and harmonization and any reciprocal arrangement to import/export with the neighboring countries. - Determining potential human resource constraints and ways to strengthen technical capabilities to enable technology transfer focused on research and development, manufacturing, and quality assurance. - Conducting a comparative analysis of key regulatory constraints and investment incentives focusing on special economic zones with other major hubs in Sub-Saharan Africa (SSA). - Assessing relevant business models to address operational constraints.

Additional Documents

No Additional Documents are available..!